Precision Biosciences Inc (DTIL)

Apr 01, 2025

Precision BioSciences to Participate in the 24th Annual Needham Virtual Healthcare Conference - BioSpace

Apr 01, 2025

Apr 01, 2025

Gene Editing Pioneer Precision BioSciences Reveals Latest ARCUS Platform Progress at Major Healthcare Conference - Stock Titan

Apr 01, 2025

Mar 28, 2025

Precision Biosciences director Kevin Buehler buys $21,122 in stock By Investing.com - Investing.com Australia

Mar 28, 2025

Mar 28, 2025

Precision Biosciences director Melinda Brown buys $8,735 in stock By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Precision Biosciences director Kevin Buehler buys $21,122 in stock - Investing.com India

Mar 28, 2025

Mar 28, 2025

Precision Biosciences director Melinda Brown buys $8,735 in stock - Investing.com India

Mar 28, 2025

Mar 27, 2025

Precision BioSciences (DTIL) Reports Q4 Loss, Misses Revenue Estimates - MSN

Mar 27, 2025

Mar 27, 2025

Precision Biosciences director Germano Geno J purchases $17,225 in stock By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

Precision Biosciences director Germano Geno J purchases $17,225 in stock - Investing.com India

Mar 27, 2025

Mar 27, 2025

Precision BioSciences: Q4 Earnings Snapshot - Big Rapids Pioneer

Mar 27, 2025

Mar 26, 2025

Precision BioSciences Reports Positive 2024 Financial Results - TipRanks

Mar 26, 2025

Mar 26, 2025

Precision BioSciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025

Mar 26, 2025

PRECISION BIOSCIENCES Earnings Results: $DTIL Reports Quarterly Earnings - Nasdaq

Mar 26, 2025

Mar 26, 2025

Precision Biosciences Reports Fourth Quarter And FY 2024 Results - MarketScreener

Mar 26, 2025

Mar 26, 2025

Precision BioSciences Inc Q4 Sales Decline - Nasdaq

Mar 26, 2025

Mar 26, 2025

Breakthrough: Precision BioSciences' Gene Editing Therapy Delivers First Results in HBV Patients - Stock Titan

Mar 26, 2025

Mar 25, 2025

Precision Biosciences CEO sells $5,359 in stock By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Precision Biosciences CEO sells $5,359 in stock - Investing.com India

Mar 25, 2025

Mar 25, 2025

Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases - Business Wire

Mar 25, 2025

Mar 23, 2025

PRECISION BIOSCIENCES Earnings Preview: Recent $DTIL Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 23, 2025

Mar 23, 2025

Gene Editing Tools Market Growth Demand, Segment Analysis - openPR.com

Mar 23, 2025

Mar 21, 2025

Precision BioSciences to Report Fourth Quarter and Fiscal Year 2024 Results on March 26, 2025 - BioSpace

Mar 21, 2025

Mar 21, 2025

Precision BioSciences Presents Preclinical Safety and Efficacy Data Supporting Repeat Dosing of PBGENE-HBV With a Goal of Curing Chronic Hepatitis B at the Global Hepatitis Summit 2025 - Business Wire

Mar 21, 2025

Mar 21, 2025

Precision BioSciences Earnings Call: Key ARCUS Gene Editing Platform Updates Expected March 26 - StockTitan

Mar 21, 2025

Mar 20, 2025

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 20, 2025

Mar 20, 2025

H.C. Wainwright maintains $60 target on Precision BioSciences stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

H.C. Wainwright maintains $60 target on Precision BioSciences stock - Investing.com

Mar 20, 2025

Mar 20, 2025

Revolutionary Gene Therapy Achieves 99% Hepatitis B Virus EliminationKey Trial Updates - Stock Titan

Mar 20, 2025

Mar 19, 2025

Precision Bio rises after gene editing data: BMO upgrades (update) - MSN

Mar 19, 2025

Mar 19, 2025

Assessing Precision BioSciences: Insights From 4 Financial Analysts - Benzinga

Mar 19, 2025

Mar 19, 2025

FDA Clears First-Ever In Vivo Gene-Editing Trial for Chronic Hepatitis B in the United States - CRISPR Medicine News

Mar 19, 2025

Mar 19, 2025

Precision BioSciences Presents Preclinical Efficacy and Durability Data on PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy (DMD) at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - 01Net

Mar 19, 2025

Mar 19, 2025

Revolutionary DMD Treatment Restores 93% Muscle Strength, Could Help 60% of Patients - StockTitan

Mar 19, 2025

Mar 17, 2025

Precision BioSciences' IND Application For PBGENE-HBV Gets FDA Clearance; Stock Climbs - RTTNews

Mar 17, 2025

Mar 17, 2025

Precision Says its Investigational New Drug Application for Hepatitis B Treatment Gets US FDA's Clearance - MarketScreener

Mar 17, 2025

Mar 17, 2025

Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - NewsBreak: Local News & Alerts

Mar 17, 2025

Mar 17, 2025

Precision BioSciences Announces Clearance of Investigational New Drug Application by the U.S. FDA for First-in-Class PBGENE-HBV Designed to Eliminate Root Cause of Chronic Hepatitis B - BioSpace

Mar 17, 2025

Mar 15, 2025

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL) - Seeking Alpha

Mar 15, 2025